[May 22, 2012] MAP Pharmaceuticals Down 23.1% Since SmarTrend Downtrend Call (MAPP) Tweet May 22, 2012 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified a Downtrend for MAP Pharmaceuticals (NASDAQ:MAPP) on March 16th, 2012 at $15.08. In approximately 2 months, MAP Pharmaceuticals has returned 23.05% as of today's recent price of $11.60. In the past 52 weeks, shares of MAP Pharmaceuticals have traded between a low of $10.54 and a high of $17.92 and are now at $11.60, which is 10% above that low price. The 200-day and 50-day moving averages have moved 0.27% lower and 2.28% lower over the past week, respectively. MAP Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops treatments for respiratory and CNS diseases. SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of MAP Pharmaceuticals. Log in and add MAP Pharmaceuticals (MAPP) to your watchlist today so you can receive a real-time alert when the shares are about to change trend. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]